April 20, 2023 Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer’s disease
March 25, 2023 The Role of the Complement Pathway in Clinical Progression of Geographic Atrophy: Analysis of the Phase III Chroma and Spectri Trials
November 25, 2022 Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity
November 3, 2022 Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays
November 3, 2022 Single-molecule array assay reveals the prognostic impact of plasma LRIG1 in ovarian carcinoma
October 17, 2022 Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial
August 11, 2022 Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease